학술논문

BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir
Document Type
Article
Source
In: Antimicrobial Agents and Chemotherapy. (Antimicrobial Agents and Chemotherapy, April 2024, 68(4))
Subject
Language
English
ISSN
10986596
00664804